239 related articles for article (PubMed ID: 23220998)
21. Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker.
Liu J; Chen Y; Yuan F; Hu L; Bei W; Chen H
Can J Vet Res; 2011 Jul; 75(3):183-90. PubMed ID: 22210994
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
[TBL] [Abstract][Full Text] [Related]
23. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
[TBL] [Abstract][Full Text] [Related]
24. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
[TBL] [Abstract][Full Text] [Related]
25. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
van den Bosch H; Frey J
Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of glutathione-binding protein A of Haemophilus parasuis as a vaccine candidate in a mouse model.
Zhang Y; Li G; Xie F; Liu S; Wang C
J Vet Med Sci; 2017 Jan; 79(1):184-187. PubMed ID: 27840377
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge.
Cao Y; Gao L; Zhang L; Zhou L; Yang J; Deng L; Zhao J; Qi C; Liu J
Sci Rep; 2020 Feb; 10(1):2343. PubMed ID: 32047221
[TBL] [Abstract][Full Text] [Related]
28. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
Loera-Muro A; Angulo C
Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
[TBL] [Abstract][Full Text] [Related]
29. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine.
Fuller TE; Thacker BJ; Duran CO; Mulks MH
Vaccine; 2000 Jun; 18(25):2867-77. PubMed ID: 10812230
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model.
Yuan F; Fu S; Hu J; Li J; Chang H; Hu L; Chen H; Tian Y; Bei W
Res Vet Sci; 2012 Aug; 93(1):51-6. PubMed ID: 21596404
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of recombinant protein superoxide dismutase of Haemophilus parasuis strain SH0165 as vaccine candidate in a mouse model.
Guo L; Xu L; Wu T; Fu S; Qiu Y; Hu CA; Ren X; Liu R; Ye M
Can J Microbiol; 2017 Apr; 63(4):312-320. PubMed ID: 28177794
[TBL] [Abstract][Full Text] [Related]
32. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.
Inzana TJ; Todd J; Veit HP
Infect Immun; 1993 May; 61(5):1682-6. PubMed ID: 8478056
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
34. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
Hau SJ; Eberle KC; Brockmeier SL
Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
[TBL] [Abstract][Full Text] [Related]
35. Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5.
Li M; Song S; Yang D; Li C; Li G
Vaccine; 2015 Mar; 33(14):1695-701. PubMed ID: 25704800
[TBL] [Abstract][Full Text] [Related]
36. Immune response to oligopeptide permease A (OppA) protein in pigs naturally and experimentally infected with Haemophilus parasuis.
Macedo N; Oliveira S; Torremorell M; Rovira A
Res Vet Sci; 2016 Aug; 107():62-67. PubMed ID: 27473976
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.
MacInnes JI; Gottschalk M; Lone AG; Metcalf DS; Ojha S; Rosendal T; Watson SB; Friendship RM
Can J Vet Res; 2008 Apr; 72(3):242-8. PubMed ID: 18505187
[TBL] [Abstract][Full Text] [Related]
38. Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice.
Fu S; Zhang M; Ou J; Liu H; Tan C; Liu J; Chen H; Bei W
Vaccine; 2012 Nov; 30(48):6839-44. PubMed ID: 23000128
[TBL] [Abstract][Full Text] [Related]
39. Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination.
Prideaux CT; Pierce L; Krywult J; Hodgson AL
Curr Microbiol; 1998 Nov; 37(5):324-32. PubMed ID: 9767712
[TBL] [Abstract][Full Text] [Related]
40. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
